Equity Overview
Price & Market Data
Price: $39.91
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $4,192,784,896
Daily Volume: 0
Performance Metrics
1 Week: -6.03%
1 Month: 44.03%
3 Months: 103.9%
6 Months: 55.96%
1 Year: 55.96%
YTD: 50.60%
Company Details
Employees: 81
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, New York.